SEC Form 4 · accession 0001628280-18-012481

Guardant Health, Inc. · GH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Oct 9, 2018

Accepted (ET)

Oct 11, 2018 · 4:28 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001576280

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
COMMON STOCK^F1	Oct 9, 2018	C	87,753	—	A	119,550	I	Shares held by Helmy A. Eltoukhy Revocable Trust
COMMON STOCK^F1	Oct 9, 2018	C	4,040,370	—	A	4,040,370	D
COMMON STOCK^F1	Oct 9, 2018	C	73,780	—	A	73,780	I	Shares held by Isabella Eltoukhy 2018 Irrevocable Trust
COMMON STOCK^F1	Oct 9, 2018	C	73,780	—	A	73,780	I	Shares held by Camille Eltoukhy Irrevocable Trust
COMMON STOCK^F1	Oct 9, 2018	C	664,020	—	A	664,020	I	Shares held by Eltoukhy Investments, L.P.
COMMON STOCK^F1	Oct 9, 2018	C	73,780	—	A	73,780	I	Shares held by Genevieve Eltoukhy 2018 Irrevocable Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
SERIES A PREFERRED STOCK^F1	—	Oct 9, 2018	C	87,753	A	—	—	COMMON STOCK	87,753	0	D

F1The shares of Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at the then-effective conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Certificate of Incorporation) immediately prior to the consummation of the Issuer's initial public offering, and have no expiration date.

Exhibit 24.1-Power of Attorney